La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: dati al basale del Registro Europeo PREFER in AF
View Full Paper
Ask AI
Bookmark
Share
Key result
Italian patients with atrial fibrillation had the lowest prescription rate of vitamin K antagonists (71.6% vs 78.3% European average) and reported lower levels of treatment satisfaction compared to other European countries.
Population
1,888 Italian patients with atrial fibrillation documented during the previous 12 months, recruited in…
Design
Cohort
Follow-up
baseline
Authors
Discussion
Loading...
Member takes
Implication
Lower VKA use and satisfaction in Italian AF patients highlight care gaps; leaves open regional drivers and improvement strategies.
Study Design
Type
Observational (n=7,243)
Multicenter
Yes
Structured PICO
P
Population
7,243 European patients (including 1,888 in Italy) aged 18 and older with atrial fibrillation documented in the previous 12 months, assessed at baseline for thromboembolic risk management.
O
Outcome
Patterns of prescriptions, patient adherence to guidelines, clinical features, quality of life, and treatment satisfaction at baseline
Main Result
Absolute Event Rate: 71.6% vs 78.3%
Italian patients with atrial fibrillation exhibit lower rates of vitamin K antagonist prescription, higher frequency of INR monitoring, and lower treatment satisfaction compared to other Western European countries.
Limitations
- Selection bias of centers, as cardiology centers were privileged over other potential reference centers for AF patients.
- Possible selection bias at the center or patient level, common to other similar registries.
- Data represents an approximation of the global reality of AF in Italy, mainly reflecting cardiology centers.
Cite This Study
Caterina et al. (2014) conducted an observational in Atrial fibrillation (n=7,243). Atrial fibrillation management practices in Italy vs. Practices in other Western European countries was evaluated on Vitamin K antagonist prescription rate. Italian patients with atrial fibrillation had the lowest prescription rate of vitamin K antagonists (71.6% vs 78.3% European average) and reported lower levels of treatment satisfaction compared to other European countries.
Topics
View Full Paper
Ask AI
Bookmark
Share